The Entrepreneur Behind a Cure: Martin Lehr’s Mission to Outsmart Cancer
Cancer touches everyone. Whether it’s a parent, a friend, or ourselves, the battle against this relentless disease is deeply personal, and Martin Lehr is on the frontlines. As co-founder and CEO of Context Therapeutics, a publicly traded biotech company, Martin is developing a powerful new class of cancer-fighting drugs known as T-cell engagers. These therapies aim to “uncloak” cancer cells, turbocharge the body’s immune response, and ultimately bend the mortality curve. This episode isn’t just a technical dive into next-gen biotech, it’s a mission-driven conversation from a founder whose fam…
